Liddicoat John R 4

4 · Medtronic plc · Filed Aug 4, 2021

Form 4

Period: 2021-08-02

EVP & President of Americas

Transactions

Award
Ordinary Shares
2021-08-02+3,353→ 42,847 total
Award
Performance Share Units
2021-08-02+8,381→ 8,381 total
→ Performance Share Units (8,381 underlying)
Tax Payment
Ordinary Shares
2021-08-02$131.31/sh−3,258$427,808→ 39,494 total
Award
Stock Option (Right to Buy)
2021-08-02+28,641→ 28,641 total
Exercise: $131.26From: 2022-08-02Exp: 2031-08-02→ Ordinary Shares (28,641 underlying)
Award
Stock Option (Right to Buy)
2021-08-02+1,085→ 1,085 total
Exercise: $131.26From: 2022-08-02Exp: 2031-08-02→ Ordinary Shares (1,085 underlying)

Footnotes (7)

[F1]This amount has been adjusted to correct a mathematical error in exempt transactions such as dividend reinvestment.
[F2]This balance increased by 284 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan.
[F3]The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date.
[F4]These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
[F5]Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
[F6]The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 8,381 shares will be issued. The actual number of shares to be issued could range from a low of 1,677 at minimum performance to a high of 16,762 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
[F7]Vests on August 2, 2024.

Documents

1 file